Ideal Pharmacy recalls Medro: Risk of contamination in injections
Ideal Pharmacy recalls Medroxyprogesterone Acetate injections due to lack of sterility assurance. All lots within expiry date are affected. Consumers should contact the company for details.
Recall notice
Lack of Assurance of Sterility
Contact the company
What happened, in plain English
Ideal Pharmacy is recalling Medroxyprogesterone Acetate injections because they may not be sterile. This could lead to infections if used improperly. The recall affects all lots within the expiry date. Read more at govinfonow.com/recall/35419-ideal-pharmacy-recalls-medro-risk-of-contamination-in-injections.
Source Summary by GovInfoNow · govinfonow.com/recall/35419-ideal-pharmacy-recalls-medro-risk-of-contamination-in-injections · Updated August 18, 2026 · FDA enforcement record: FDA #D-0463-2022
Cite this page
“Ideal Pharmacy recalls Medro: Risk of contamination in injections.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35419-ideal-pharmacy-recalls-medro-risk-of-contamination-in-injections. Based on FDA recall #D-0463-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0463-2022%22&limit=1).
Why it’s dangerous
The injections may not be sterile, which can cause infections if the product is used. This is a serious risk for medical treatments that require clean injections.
Who’s affected
People who have received the recalled injections from Ideal Pharmacy in New Jersey. Those using the product for medical treatments are at risk.
How to tell if you have this one
Check for the product name 'Medroxyprogesterone Acetate Injection, IM, 150 mg/mL, packaged in 1 ml Single Dose Vial' from Ideal Pharmacy. All lots within the expiry date are affected.
- Brand
Ideal Pharmacy- Category
Drug
What to do — step by step
Contact Ideal Pharmacy
Reach out to Ideal Pharmacy at 2333 Morris Ave, Union, NJ 07083 for specific details about the recalled product.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 50 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0463-2022 (December 21, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0463-2022 to see it in context.
- Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.